Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE
Jeffrey I. Weitz, Alfredo E. Farjat, Walter Ageno, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 12, pp. 3031-3043
Closed Access | Times Cited: 16

Showing 16 citing articles:

Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
European Journal of Internal Medicine (2023) Vol. 118, pp. 59-72
Open Access | Times Cited: 24
Combination of Biological Aging and Genetic Susceptibility Helps Identifying At‐Risk Population of Venous Thromboembolism: A Prospective Cohort Study of 394 041 Participants
Zhensheng Hu, Jiatang Xu, Runnan Shen, et al.
American Journal of Hematology (2025)
Closed Access
Lower early mortality and risk prediction improvement of obesity after acute pulmonary embolism: Results from a multicenter cohort analysis with external validation
Romain Chopard, Laurent Bertoletti, Marc Badoz, et al.
Research and Practice in Thrombosis and Haemostasis (2025) Vol. 9, Iss. 2, pp. 102718-102718
Open Access
Obesity as a Risk Factor for Venous Thromboembolism Recurrence: A Systematic Review
Pinelopi Ntinopoulou, Erato Ntinopoulou, Ioanna V. Papathanasiou, et al.
Medicina (2022) Vol. 58, Iss. 9, pp. 1290-1290
Open Access | Times Cited: 16
Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis
Paschalis Karakasis, Nikolaos Ktenopoulos, Konstantinos Pamporis, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3784-3784
Open Access | Times Cited: 3
Stratification of Risk Factors of Lung Cancer-Associated Venous Thromboembolism and Determining the Critical Point for Preemptive Intervention: A Systematic Review With Meta-analysis
Theresa Ukamaka Nwagha, Martins Nweke
Clinical Medicine Insights Oncology (2023) Vol. 17
Open Access | Times Cited: 7
Risk Factors for Bleeding in Cancer Patients Treated with Conventional Dose Followed by Low-Dose Apixaban for Venous Thromboembolism
Parwana Hussaini, Trine‐Lise Larsen, Waleed Ghanima, et al.
Thrombosis and Haemostasis (2023) Vol. 124, Iss. 04, pp. 351-362
Closed Access | Times Cited: 4
Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism
Kingsley Dah, Mateo Porres‐Aguilar, Alan De la Rosa, et al.
Jornal Vascular Brasileiro (2023) Vol. 22
Open Access | Times Cited: 3
Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review
Victoria Speed, Julia Czuprynska, Jignesh P. Patel, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 8, pp. 102240-102240
Open Access | Times Cited: 3
Provoked vs minimally provoked vs unprovoked VTE: does it matter?
Cecilia Becattini, Ludovica Anna Cimini
Hematology (2023) Vol. 2023, Iss. 1, pp. 600-605
Closed Access | Times Cited: 3
A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches
Ezekwesiri Michael Nwanosike, Wendy Sunter, Muhammad Ayub Ansari, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 3, pp. 287-299
Closed Access | Times Cited: 2
Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”
Samuel Z. Goldhaber
Thrombosis and Haemostasis (2023)
Closed Access | Times Cited: 2
Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
Christian Fielder Camm, Saverio Virdone, Shinya Goto, et al.
Open Heart (2022) Vol. 9, Iss. 2, pp. e002038-e002038
Open Access | Times Cited: 4
Factor Xa Inhibitor Plasma Concentrations and Clinical Outcomes in Patients Weighing ≤50 kg—Experience from Four UK Centers
Victoria Speed, Rachel E. Clapham, J. Bartoli-Abdou, et al.
Thrombosis and Haemostasis (2023) Vol. 124, Iss. 02, pp. 177-180
Closed Access | Times Cited: 1
Venous Thromboembolism Prophylaxis in Low Body Weight Critically Ill Patients
Helena Knox, Stephanie B. Edwin, Christopher Giuliano, et al.
Journal of Intensive Care Medicine (2023) Vol. 39, Iss. 5, pp. 493-498
Closed Access | Times Cited: 1
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial
Arzu Kalaycı, C. Michael Gibson, Adrian F. Hernandez, et al.
Thrombosis Research (2022) Vol. 211, pp. 63-69
Closed Access | Times Cited: 1
Direct oral anticoagulants and the risk of adverse clinical outcomes among patients with different body weight categories: a large hospital-based study
Ezekwesiri Michael Nwanosike, Hamid A. Merchant, Wendy Sunter, et al.
European Journal of Clinical Pharmacology (2023) Vol. 80, Iss. 1, pp. 163-173
Open Access
Page 1

Scroll to top